Equal-WT
WhaleScore 2.0
?
Cormorant Asset Management is based out of Boston. Cormorant Asset Management is a hedge fund with 12 clients and discretionary assets under management (AUM) of $3,117,053,633 (Form ADV from 2023-03-31). Their last reported 13F filing for Q3 2023 included $1,714,347,327 in managed 13F securities
and a top 10 holdings concentration of 65.15%. Cormorant Asset Management's largest holding is MoonLake Immunotherapeutics with shares held of 8,142,100. Whalewisdom has at least 41 13F filings, 3 13D filings, 210 13G filings, and 66 Form 4 filings
2023-09-30
Top Buys (13F)
| Name | % Change |
|---|---|
| BBIO BridgeBio Pharma Inc | 3.15% |
| IMVT Immunovant Inc | 2.16% |
| CRNX Crinetics Pharmaceut | 1.91% |
| GPCR Structure Therapeuti | 1.76% |
| OLMA Olema Pharmaceutical | 1.69% |
2023-09-30
Top Sells (13F)
| Name | % Change |
|---|---|
| PTGX Protagonist Therapeu | 2.32% |
| DSGN Design Therapeutics | 1.82% |
| ETNB 89bio, Inc. | 1.43% |
| AXSM Axsome Therapeutics | 1.37% |
| ELVN Enliven Therapeutics | 1.24% |
2023-09-30
13F Holdings Summary
| Name | $ Change |
|---|---|
| MLTX MoonLake Immunothera | 27.07% |
| BBIO BridgeBio Pharma Inc | 7.17% |
| AMAM Ambrx Biopharma Inc. | 6.66% |
| ACLX Arcellx Inc | 4.5% |
| APLS Apellis Pharmaceutic | 4.44% |
2023-09-30
13F Activity
| Market Value | $1.71b, Prior: $1.79b |
| New Purchases | 6 stocks |
| Additional Purchases | 13 stocks |
| Sold out of | 21 stocks |
| Reduced holdings in | 5 stocks |
| Top 10 Holdings % | 65.15% |
| Turnover %[1] | 55.1% |
| Turnover Alt %[2] | 16.89% |
| Time Held Top 20 | 1.75 quarters |
| Time Held Top 10 | 2.1 quarters |
| Time Held All | 7.94 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-09-30
13F Sector Allocation Over Time
2023-09-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-09-30